Israel Englander Esperion Therapeutics, Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 300,000 shares of ESPR stock, worth $504,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

300,000

Previous 5,681,744 94.72%

Holding current value

$504,000

Previous $15.2 Million 95.63%

% of portfolio

0.0%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.84 - $3.24 $1.53 Million - $2.7 Million	832,188 Added 14.65%	6,513,932 $14.5 Million
Q1 2024 May 15, 2024	BUY	$2.02 - $3.02 $4.51 Million - $6.74 Million	2,232,293 Added 64.71%	5,681,744 $15.2 Million
Q4 2023 Feb 14, 2024	BUY	$0.73 - $3.08 $74,989 - $316,393	102,725 Added 3.07%	3,449,451 $10.3 Million
Q2 2023 Aug 14, 2023	SELL	$1.2 - $1.76 $394,257 - $578,244	-328,548 Reduced 8.94%	3,346,726 $4.65 Million
Q1 2023 May 15, 2023	BUY	$1.46 - $7.3 $2.11 Million - $10.6 Million	1,448,465 Added 65.05%	3,675,274 $5.84 Million
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $2.56 Million - $4.28 Million	503,634 Added 29.23%	2,226,809 $13.9 Million
Q3 2022 Nov 14, 2022	SELL	$5.45 - $8.13 $5.36 Million - $7.99 Million	-983,115 Reduced 36.33%	1,723,175 $11.5 Million
Q2 2022 Aug 15, 2022	BUY	$4.77 - $6.67 $6.95 Million - $9.72 Million	1,457,952 Added 116.79%	2,706,290 $17.2 Million
Q1 2022 May 16, 2022	BUY	$3.34 - $5.56 $3.05 Million - $5.08 Million	913,908 Added 273.27%	1,248,338 $5.79 Million
Q4 2021 Feb 14, 2022	SELL	$4.81 - $11.92 $639,095 - $1.58 Million	-132,868 Reduced 28.43%	334,430 $1.67 Million
Q3 2021 Nov 15, 2021	BUY	$11.34 - $21.37 $1.71 Million - $3.21 Million	150,365 Added 47.44%	467,298 $5.63 Million
Q2 2021 Aug 16, 2021	SELL	$19.4 - $28.71 $110,211 - $163,101	-5,681 Reduced 1.76%	316,933 $6.7 Million
Q1 2021 May 17, 2021	BUY	$25.12 - $36.89 $4.61 Million - $6.77 Million	183,573 Added 132.03%	322,614 $9.05 Million
Q4 2020 Feb 16, 2021	SELL	$24.2 - $35.76 $3.08 Million - $4.54 Million	-127,092 Reduced 47.76%	139,041 $3.62 Million
Q3 2020 Nov 16, 2020	SELL	$31.18 - $52.71 $8.2 Million - $13.9 Million	-263,006 Reduced 49.7%	266,133 $9.89 Million
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $13.3 Million - $22.8 Million	443,974 Added 521.31%	529,139 $27.2 Million
Q1 2020 May 14, 2020	SELL	$27.44 - $73.84 $4.75 Million - $12.8 Million	-172,986 Reduced 67.01%	85,165 $2.69 Million
Q4 2019 Feb 14, 2020	BUY	$35.4 - $59.82 $6.24 Million - $10.5 Million	176,164 Added 214.87%	258,151 $15.4 Million
Q3 2019 Nov 14, 2019	SELL	$34.47 - $47.53 $3.16 Million - $4.36 Million	-91,697 Reduced 52.8%	81,987 $3.01 Million
Q2 2019 Aug 15, 2019	SELL	$40.1 - $52.33 $11.6 Million - $15.1 Million	-288,569 Reduced 62.43%	173,684 $8.08 Million
Q2 2019 Aug 14, 2019	BUY	$40.1 - $52.33 $8.58 Million - $11.2 Million	214,080 Added 86.26%	462,253 $2.26 Million
Q1 2019 May 14, 2019	BUY	$40.11 - $53.57 $6.64 Million - $8.87 Million	165,637 Added 200.68%	248,173 $9.96 Million
Q4 2018 Feb 14, 2019	BUY	$36.99 - $59.11 $1.87 Million - $2.99 Million	50,599 Added 158.43%	82,536 $3.8 Million
Q3 2018 Nov 14, 2018	SELL	$40.74 - $51.41 $2.24 Million - $2.82 Million	-54,880 Reduced 63.21%	31,937 $1.42 Million
Q2 2018 Aug 14, 2018	SELL	$36.2 - $76.4 $1.73 Million - $3.64 Million	-47,686 Reduced 35.45%	86,817 $3.4 Million
Q1 2018 May 15, 2018	SELL	$65.94 - $80.76 $16.7 Million - $20.5 Million	-253,444 Reduced 65.33%	134,503 $9.73 Million
Q4 2017 Feb 14, 2018	BUY	$43.47 - $67.43 $15.4 Million - $23.9 Million	354,580 Added 1062.67%	387,947 $25.5 Million
Q3 2017 Nov 14, 2017	BUY	$43.8 - $52.77 $1.46 Million - $1.76 Million	33,367	33,367 $1.67 Million

Others Institutions Holding ESPR

# of Institutions

199

Shares Held

136M

Call Options Held

2.72M

Put Options Held

1.3M

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $112M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account